Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction

Circulation Journal - Japan
doi 10.1253/circj.cj-10-0109
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Circulation Society

Related search

Acute Myocardial Infarction After Administration of Low-Dose Intravenous Epinephrine for Anaphylaxis

Canadian Journal of Emergency Medicine
Emergency Medicine
2006English

Administration of Erythropoietin in Patients With Acute Myocardial Infarction: Good or Not?

Heart
Cardiovascular MedicineCardiology
2012English

Method for Intravenous Administration of Heparin in Myocardial Infarction

BMJ
1963English

Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke Can Cause Inferior Myocardial Infarction?

Neurology International
Neurology
2016English

Intravenous Thrombolysis in Acute Myocardial Infarction

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2001English

Hypotensive Treatment for Acute Myocardial Infarction.

BMJ
1975English

Study of Hemodialysis Patients Who Do Not Require Administration of Recombinant Human Erythropoietin.

Nihon Toseki Igakkai Zasshi
2000English

Erythropoietin-Induced Progenitor Cell Mobilisation in Patients With Acute ST-segment-elevation Myocardial Infarction and Restenosis

Thrombosis and Haemostasis
Hematology
2012English

Dose-Dependent Neurorestorative Effects of Delayed Treatment of Traumatic Brain Injury With Recombinant Human Erythropoietin in Rats

Journal of Neurosurgery
SurgeryNeurology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy